R3 Vascular Inc.

Jane BeggsVP Clinical/Regulatory/Quality Jane has defined and implemented regulatory, clinical and quality strategies for drug-delivery (coronary bioresobable stents), gastrointestinal endoscopy (stenting and gastroplasty), tools for spinal decompression, software-driven technology (dermatological lasers) and immunoassay in-vitro diagnostics. Andrew FordDirector/Clinical Affairs Andy has 40 years of experience managing, designing, implementing, and analyzing first-in-human feasibility to pivotal clinical studies in the US, Europe, South America, and Asia. Operations, R&D Leader Chang has over 15 years of experience in medical device R&D and product development ranging from implantable drug/device combination devices to wearable electronic medical products. Afsoon FalahiOperations Leader, Polymer Engineering, API, Formulations Afsoon is a polymer and biomaterial scientist/engineer with substantial experience in materials and polymer engineering, bio-materials, Drug/Nanoparticle synthesis and characterizations, biomedical devices, flexible smart electronics in both industry and academia. Frederik GroenewegenFrederik is a Co-Founder and General Partner of 415 CAPITAL. Amir Abolfathi Innovative and results-driven healthcare executive with track record of success. Experienced in driving product, process, commercialization and corporate strategy, working through difficult clinical and regulatory challenges, reimbursements, lobbying, building, and motivating world-class cross-functional teams.